Provided by Tiger Trade Technology Pte. Ltd.

MannKind

5.54
+0.01000.18%
Post-market: 5.48-0.0640-1.16%19:53 EST
Volume:2.90M
Turnover:16.11M
Market Cap:1.70B
PE:56.59
High:5.67
Open:5.51
Low:5.46
Close:5.53
52wk High:6.51
52wk Low:3.38
Shares:307.07M
Float Shares:300.98M
Volume Ratio:1.51
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0979
EPS(LYR):0.1000
ROE:32.74%
ROA:9.95%
PB:-38.18
PE(LYR):55.40

Loading ...

MannKind CEO Michael Castagna to Present at Oppenheimer Healthcare Life Sciences Conference

Reuters
·
Feb 19

MannKind Corporation Schedules Webcast to Review Financial Results and Business Update

Reuters
·
Feb 18

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

GlobeNewswire
·
Feb 18

MannKind’s Pediatric Afrezza Trial Puts Needle Free Insulin Thesis To Test

Simply Wall St.
·
Feb 16

MannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential

TIPRANKS
·
Feb 10

BRIEF-Mannkind Announces First Patient Enrolled In Inhale-1St Pediatric Study Evaluating Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes (T1d)

Reuters
·
Feb 09

MannKind says first patient enrolled in INHALE-1ST study of Afrezza

TIPRANKS
·
Feb 09

FDA prüft Zulassung von Afrezza Inhalationsinsulin für Kinder und Jugendliche

Reuters
·
Feb 09

MannKind Announces First Patient Enrolled in Inhale-1St Pediatric Study Evaluating Afrezza® for Youth With Newly-Diagnosed Type 1 Diabetes (T1d)

THOMSON REUTERS
·
Feb 09

Does Afrezza’s New Dosing Label Meaningfully Change The Bull Case For MannKind (MNKD)?

Simply Wall St.
·
Feb 07

The Bull Case For MannKind (MNKD) Could Change Following FDA-Backed Afrezza Dosing Label Update

Simply Wall St.
·
Jan 31

BUZZ-U.S. STOCKS ON THE MOVE-US natgas companies

Reuters
·
Jan 26

MannKind Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 26

MannKind Shares Rise 5% Premarket After US FDA Updates Label for Inhaled Insulin Afrezza

THOMSON REUTERS
·
Jan 26

BUZZ-U.S. STOCKS ON THE MOVE-Baker Hughes, Allied Gold Corp, MannKind Corp

Reuters
·
Jan 26

MannKind receives FDA approval for Afrezza dosage label

TIPRANKS
·
Jan 26

BRIEF-MannKind Announces FDA Approval of Updated Afrezza Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy

Reuters
·
Jan 26

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance When Switching From Multiple Daily Injections (Mdi) or Insulin Pump Mealtime Therapy

THOMSON REUTERS
·
Jan 26

6 stocks and ETFs that these unsung market heroes see outperforming in 2026

Dow Jones
·
Jan 18

MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch

TIPRANKS
·
Jan 17